Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the α(v)β3 integrin, osteopontin, and thrombin

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 293-305

  Senger, Donald R ^a   Ledbetter, Steven R ^b   Claffey, Kevin P ^a   Papadopoulos Sergiou, Ageliki ^a   Perruzzi, Carole A ^a   Detmar, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; OSTEOPONTIN; RECOMBINANT VASCULOTROPIN; THROMBIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; GUINEA PIGS; HUMANS; INFANT, NEWBORN; INTEGRINS; LYMPHOKINES; MALE; OSTEOPONTIN; RECEPTORS, VITRONECTIN; RNA, MESSENGER; SIALOGLYCOPROTEINS; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029999603     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Folkman J, Shing Y: Minireview: Angiogenesis. J Biol Chem 1992, 267:10931-10934
2. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley B, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84:1470-1478
3. Wilting J, Christ B, Bokeloh M, Weich HA: In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993, 274: 163-172
4. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu L-Q, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994, 93:662-670
5. Potgens AJG, Lubsen NH, van Altena MC, Schoenmakers JGG, Ruiter DJ, de Waal RMW: Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 1995, 146:197-209
6. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo K-T, Manseau EJ, Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996, 56:172-181
7. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255: 989-991
8. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the kdr tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992, 187:1579-1586
9. Mustonen T, Alitalo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995, 129:895-898
10. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A: High affinity VEGF binding and development expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846
11. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993, 90:7533-7537
12. Peters KG, De Vries C, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993, 90:8915-8919
13. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HG, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993, 143:1255-1262
14. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993, 53:4727-4735
15. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993, 91:153-159
16. Brown LF, Yeo K-T, Berse B, Yeo T-K, Senger DR, Dvorak HF, Van De Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992, 176:1375-1379
17. Fava RA, Olsen NJ, Spencer-Green G, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF: Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994, 180:341-346
18. Detmar M, Brown LF, Claffey KP, Yeo K-T, Kocher O, Jackman RW, Berse B, Dvorak HF: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994, 180:11421-11426
19. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487
20. Adamis AP, Miller JW, Bernai M-T, D'Amico DJ, Folkman J, Yeo T-K, Yeo K-T: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Opthalmol 1994, 118:445-450
21. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995, 92:905-909
22. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844
23. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995, 95:1789-1797
24. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161:851-858
25. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived follicule stellate cells. Proc Natl Acad Sci USA 1989, 86:7311-7315
26. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985
27. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990, 50:1774-1778
28. Dvorak HF, Senger DR, Harvey VS, McDonagh J: Regulation of extravascular coagulation by microvascular permeability. Science 1985, 227:1059-1061
29. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
30. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991, 181:902-906
31. Akiyama SK, Yamada SS, Chen WT, Yamada KM: Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989, 109:863-875
32. Yamada KM, Kennedy DW, Yamada SS, Gralnick H, Chen WT, Akiyama SK: Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res 1990, 50:4485-4496
33. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA: Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 1992, 117:1101-1107
34. Bauer JS, Schreiner CL, Giancotti FG, Ruoslahti E, Juliano RL: Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins. J Cell Biol 1992, 116:477-487
35. Detmar M, Yeo K-T, Nagy JA, Van De Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF: Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995, 105:44-50
36. Denhardt DT, Guo X: Osteopontin: a protein with diverse functions. FASEB J 1993, 7:1475-1482
37. Rodan GA: Osteopontin overview. Ann NY Acad Sci 1995, 760:1-5
38. 3 for angiogenesis. Science 1994, 264:569-571
39. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79:1157-1164
40. 3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 1995, 108: 2655-2661
41. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van De Water L: Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 1994, 5:565-574
42. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994, 74:214-224
43. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 1995, 95:713-724
44. Detmar M, Imcke E, Ruszczak Z, Orfanos CE: Effects of recombinant tumor necrosis factor-α on cultured microvascular endothelial cells derived from human dermis. J Invest Dermatol 1990, 39:2195-2225
45. Imcke E, Ruszczak Z, Mayer-da-Silva A, Detmar M, Orfanos CE: Cultivation of human dermal microvascular endothelial cells in vitro: immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids. Arch Dermatol Res 1991, 283:149-157
46. Yeo K-T, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo T-K: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993, 53:2912-2918
47. Claffey KP, Wilkison WO, Spiegelman BM: Vascular endothelial growth factor: regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992, 267:16317-16322
48. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
49. Kiefer MC, Bauer DM, Barr PJ: The cDNA and derived amino acid sequence for human osteopontin. Nucleic Acids Res 1989, 17:3306
50. Fitzgerald LA, Steiner B, Rall SC, Lo S-S, Phillips DR: Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. J Biol Chem 1987, 262:3936-3939
51. Fitzgerald LA, Poncz M, Steiner B, Rall SC, Bennett JS, Phillips DR: Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor α-subunits and platelet glycoprotein IIb. Biochemistry 1987, 26:8158-8165
52. Semenkovich CF, Ostlund RE Jr, Olson MOJ, Yang JW: A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 1990, 29:9708-9713
53. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
54. Senger DR, Perruzzi CA, Papadopoulos A, Tenen DG: Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta 1989, 996:43-48
55. Cheresh DA, Spiro RC: Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem 1987, 262:17703-17711
56. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992, 13: 18-32
57. Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993, 264:C995-C1002
58. Prince CW, Dickie D, Krumdieck CL: Osteopontin, a substrate for transglutaminase, and factor XIII activity. Biochem Biophys Res Commun 1991, 177:1205-1210
59. Beninati S, Senger DR, Cordella-Miele E, Mukherjee AB, Chackalaparampil I, Shanmugam V, Singh K, Mukherjee BB: Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J Biochem 1994, 115:675-682
60. Bendixen E, Borth W, Harpel PC: Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. J Biol Chem 1993, 268: 21962-21967
61. Martinez J, Chalupowicz DG, Roush RK, Sheth A, Barsigian C: Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 1994, 33:2538-2545
62. Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG: Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 1988, 48:5770-5774
63. Senger DR, Perruzzi CA, Papadopoulos A: Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 1989, 9:1291-1300
64. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25
65. Ruoslahti E, Noble NA, Kagami S, Border WA: Integrins. Kidney Int 1994, 45:S17-S22
66. 3 integrins. J Cell Sci 1993, 105:1001-1012
67. 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun 1992, 182: 1025-1031
68. Schwartz MA, Denninghoff K: αv integrins mediate the rise in intracellular calcium in endothelial cells on fibronectin even though they play a minor role in adhesion. J Biol Chem 1994, 269:11133-11137
69. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995, 267:883-885
70. v integrin subunit and osteopontin during differentiation of HL-60 cells along the monocytic pathway. Exp Cell Res 1995, 216:335-341
71. Senger DR, Brown LF, Perruzzi CA, Papadopoulos-Sergiou A, Van De Water L: Osteopontin at the tumor/ host interface: functional regulation by thrombin-cleavage and consequences for cell adhesion. Ann NY Acad Sci 1995, 760:83-100
72. Diamond MS, Springer TA: The dynamic regulation of integrin adhesiveness. Curr Biol 1994, 4:506-517
73. 5-directed cell motility but not adhesion on vitronectin. J Cell Biol 1994, 127:859-866
74. 3 integrin complex on human microvascular endothelial cells. J Invest Dermatol 1994, 103:295-299
75. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, Rifkin DB: Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell 1993, 4:973-982
76. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994, 145:610-623
77. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845
78. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994, 145:1450-1462
79. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E: Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994, 28:1176-1179
80. Brown LF, Olbricht SM, Berse B, Jackman RW, Matueda G, Tognazzi, KA, Manseau, EJ, Dvorak, HF, Van De Water, L: Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 1995, 154:2801-2807
81. Brown LF, Harrist TJ, Yeo K-T, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 1995, 104: 744-749
82. Weindel K, Moringlane JR, Marme D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis. Neurosurgery 1994, 35:439-449